endpoints.news
is our new home on June 1. endpts.com will still work, but the front door is now
https://endpoints.news
Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
California sues insulin heavyweights, PBMs over 'excessive' prices
3 years ago
Law
Ex-Takeda staffer's 'small hustle' ends with arrest and $2.3M fraud scheme charge
3 years ago
Law
EMA developing physician guidance for potential liver damage after taking Zolgensma
3 years ago
Cell/Gene Tx
Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx
3 years ago
Marketing
Most trusted: Pharma overtakes tech industry for top spot in Ipsos’ annual trustworthiness survey
3 years ago
Marketing
Digital therapeutics 2023: Swing and trial partner Curavit kick off fibromyalgia study
3 years ago
Marketing
AstraZeneca to discontinue rare blood cancer drug in the US
3 years ago
FDA+
Galderma drives diversity in dermatology with online photo gallery sponsorship
3 years ago
Marketing
Pfizer, BioNTech team up with Martha Stewart for Covid booster campaign
3 years ago
Marketing
WHO issues alert over contaminated cough syrups
3 years ago
Manufacturing
Legislators call HHS to action on Xtandi march-in rights
3 years ago
Experts talk IRA impacts as CMS announces it will publish first 10 drugs up for negotiation in September
3 years ago
R&D
Cannes Lions names jury chiefs for 2023 ad creativity show, Omnicom and VMLY&R execs helm health panels
3 years ago
Marketing
Sun Pharma facility under an import alert handed a warning letter
3 years ago
FDA+
Manufacturing
Merck leads biopharmas in annual ‘just’ business ranking, while GSK and Sanofi nab sustainability honors
3 years ago
Marketing
ICYMI: 'What could they possibly buy?' Sanofi's Paul Hudson talks M&A hesitation at #JPM23
3 years ago
Deals
Eisai chief Ivan Cheung 'not worried at all' about Leqembi's full approval
3 years ago
AstraZeneca and Avillion win approval for new asthma rescue treatment in adults
3 years ago
FDA+
Spectrum Labs issues worldwide recall of epinephrine ingredient
3 years ago
Manufacturing
Supreme Court rejects Pfizer's bid to review anti-kickback case
3 years ago
Law
Sterling Pharma completes acquisition of Novartis manufacturing plant in Ireland
3 years ago
Manufacturing
Eisai follows family ties with name for newly approved Alzheimer's drug Leqembi
3 years ago
Marketing
Q&A: Genentech's first marketing chief Erica Taylor on lessons from the pandemic, and what's next for the Roche group
3 years ago
Marketing
What we're seeing at JPM so far: Upcoming BD moves, pipeline updates and more
3 years ago
First page
Previous page
150
151
152
153
154
155
156
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit